Frailty and rheumatoid arthritis converge on illness acceptance in older adults
Older adults living with rheumatoid arthritis face more than synovitis and joint damage. In this single-centre cross-sectional study of 210 community-dwelling patients aged 65 years and older, frailty was common, psychological strain was measurable, and both conditions tracked with how patients accepted their illness. Mean age was 71.3 years, and 53.8% of participants were men. Frailty, defined by a Tilburg Frailty Indicator score of 5 or higher, was present in 75.2% of the cohort, a striking prevalence in a population already burdened by chronic inflammatory disease.
Women carried a heavier frailty burden than men: 84.5% versus 67.3%, with the difference reaching statistical significance. The pattern matters because frailty in rheumatoid arthritis is not just a geriatric label attached to age. It reflects reduced physiological reserve across mobility, strength, balance, fatigue, sensory function, weight loss, and psychosocial domains, all of which can collide with pain, stiffness, disability, and persistent inflammation. When those systems are compromised together, patients may struggle to sustain the routines that chronic treatment demands.
Disease activity and frailty moved in the same direction
Frailty aligned with several clinical and patient-reported outcomes. Higher frailty correlated with lower illness acceptance, greater disease activity, and more psychological distress. The correlation with DAS28-CRP was particularly strong for physical frailty, which reached ρ = +0.500 with p < 0.001. In practical terms, the physical component of frailty appears to capture much of the functional fallout of active inflammatory arthritis: weakened reserve, slower recovery, and worsening ability to absorb day-to-day disease burden.
A separate correlation linked frailty with lower illness acceptance, with ρ = -0.342 and p < 0.001. Psychological distress also rose with frailty, though the relationship was more modest at ρ = +0.190 and p = 0.006. These associations are clinically coherent. Persistent symptoms can erode the sense that the disease is manageable, while frailty can amplify the practical consequences of each flare, medication side effect, or missed appointment. The result is a feedback loop in which functional decline and subjective acceptance deteriorate together.
Acceptance fell as frailty and inflammatory burden increased
Multivariable models sharpened the picture. Frailty remained independently associated with lower illness acceptance, with a B coefficient of -0.34 AIS points per TFI point, and p = 0.005. Higher disease activity also independently predicted lower acceptance, with B = -0.29 and p = 0.025. Those two findings place inflammation and frailty on parallel tracks rather than competing ones. Active disease likely worsens pain and disability, while frailty reduces the reserve needed to adapt, cope, and maintain confidence in treatment.
One sentence captures the clinical tension: frailty and active arthritis were both pulling down illness acceptance at the same time.
Psychological distress did not statistically mediate the frailty-acceptance association. That leaves a direct link between frailty and lower acceptance intact, rather than explaining it away through generalized distress alone. The implication is important for bedside care. Screening only for anxiety or depressive symptoms will miss part of the burden if the patient’s main obstacle is physical vulnerability, reduced endurance, or cumulative functional loss.
Non-adherence tracked more with education than with frailty
Treatment adherence told a different story. On the surface, non-adherence was not correlated with frailty in the bivariate analysis, with ρ = 0.11 and p = 0.124. After adjustment, a small association of opposite sign emerged, with B = -0.24 and p = 0.012, described in the study as a suppression effect. The strongest signal, however, pointed elsewhere: lower educational attainment. Non-adherence was associated mainly with lower educational level, with B = -2.20 per educational level and p < 0.001.
That finding should change how clinicians think about adherence in older adults with rheumatoid arthritis. Frailty and adherence are not interchangeable constructs. A patient may be physically frail, functionally limited, and emotionally burdened yet still take medication reliably. Another patient may be less frail but miss doses, misunderstand regimens, or struggle with treatment organization because of limited health literacy or educational background. In this cohort, frailty was the dominant driver of illness acceptance, while education was the stronger marker of adherence behavior.
Routine frailty assessment fits into geriatric rheumatology care
The study used the Tilburg Frailty Indicator, a tool that captures physical, psychological, and social frailty domains. Its structure fits the complexity of older adults with inflammatory arthritis, where mobility, fatigue, sensory loss, and social vulnerability can all shape treatment experience. The findings support routine frailty assessment alongside standard rheumatologic measures such as disease activity scoring, joint counts, and inflammatory markers.
What would this change in practice? First, clinicians may need to identify frailty before assuming that low acceptance reflects simple reluctance or poor motivation. Second, psychosocial and functional support should be scaled to the frailty profile rather than delivered as a one-size-fits-all intervention. Third, adherence counseling may need to be simplified and adapted to educational level, especially in older adults who face medication schedules, polypharmacy, or limited familiarity with long-term self-management.
Because the study was cross-sectional, it cannot separate cause from consequence. Frailty may worsen acceptance, poor acceptance may weaken engagement, and active disease may drive both. Even so, the direction of the associations is consistent with what geriatric rheumatology sees at the bedside: once frailty, inflammatory burden, and reduced coping capacity overlap, treatment becomes harder to sustain and harder to live with. The cohort was single-centre as well, so generalizability should be approached carefully. Still, the sample offers a clear clinical message for older adults with rheumatoid arthritis: frailty assessment belongs in routine care, but adherence support must also account for education and the practical work of medication management.